Substituted dicinnamoylquinides and their use in...

Details Substituted dicinnamoylquinides and their use in... Substituted dicinnamoylquinides and their use in...

Category

A - Human Necessities

Subcategory

61

Subsubcategory

K

IPC codes

A61K 31/365 (2006.01) A23L 1/30 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 17/02 (2006.01) A61P 25/24 (2006.01)

Type

Patent

Patent number

CA 2347879

Description

This invention describes the novel use of alkyl, alkoxyl, halogenyl, or hydroxy substituted dicinnamoylquinides as therapeutic agents for enhancing adenosine levels in the brain and peripheral organs. These agents are particularly useful in treating human diseases or conditions that benefit from acute or chronic elevated levels of adenosine, such as reperfusion injury, coronary or cerebral ischemia, coronary vasoconstriction, paroxysmal supraventricular tachycardia, hypertension, wound healing, diabetes, inflammation, or sleep disturbances. They can also be used to protect normal cells from chemotoxicity in patients undergoing cancer therapy, and reverse the behavioral effects of caffeine intake.

Affiliated with

Also associated with

Rating

Substituted dicinnamoylquinides and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted dicinnamoylquinides and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted dicinnamoylquinides and their use in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1968276